Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Plos Biology|March 8, 2021
Sprouty2 positively regulates T cell function and airway inflammation through regulation of CSK and LCK kinasesAnand Sripada, Kapil Sirohi, Lidia Michalec, et al.Radiation Oncology (London, England)|June 14, 2020
A phase 1 trial of the safety, tolerability and biological effects of intravenous Enadenotucirev, a novel oncolytic virus, in combination with chemoradiotherapy in locally advanced rectal cancer (CEDAR)Séan M O'Cathail, Steven Davis, Jane Holmes, et al.Clinical and Translational Radiation Oncology|December 24, 2025
Daily adaptive MR-guided stereotactic ablative re-irradiation (re-SABR) in oligometastatic liver disease: A single-institution retrospective analysisElena Moreno-Olmedo, Dan Murray, Ben George, et al.The Journal of Allergy and Clinical Immunology|February 8, 2020
Optimal identification of human conventional and nonconventional (CRTH2-IL7Rα-) ILC2s using additional surface markersSucai Liu, Kapil Sirohi, Mukesh Verma, et al.The Journal of Allergy and Clinical Immunology|April 24, 2017
Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietinSucai Liu, Mukesh Verma, Lidia Michalec, et al.BJC Reports|September 2, 2024
Results and lessons learnt from the WISTERIA phase I trial combining AZD1775 with cisplatin pre- or post-operatively in head and neck cancerAnthony Kong, Amanda J Kirkham, Joshua S Savage, et al.BMJ Open|September 14, 2023
Evaluation of hypofractionated adaptive radiotherapy using the MR Linac in localised pancreatic cancer: protocol summary of the Emerald-Pancreas phase 1/expansion study located at Oxford University Hospital, UKSuliana Teoh, Alexander Ooms, Ben George, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Low-dose outpatient chemobiotherapy with temozolomide, granulocyte-macrophage colony stimulating factor, interferon-alpha2b, and recombinant interleukin-2 for the treatment of metastatic melanomaRobert W Weber, Steven O'Day, Madalene Rose, et al.International Journal of Radiation Oncology, Biology, Physics|September 18, 2012
Targeted radiosensitization by the Chk1 inhibitor SAR-020106Gerben R Borst, Martin McLaughlin, Joan N Kyula, et al.BMJ Open|March 19, 2020
Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: the WISTERIA trial protocolAnthony Kong, James Good, Amanda Kirkham, et al.Pageof 3